UK markets open in 1 hour 50 minutes

Oxford BioMedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
478.50-6.50 (-1.34%)
At close: 05:13PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 465.99M
Enterprise value 366.32M
Trailing P/E 21.85
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.84
Price/book (mrq)2.49
Enterprise value/revenue 2.57
Enterprise value/EBITDA 11.03

Trading information

Stock price history

Beta (5Y monthly) 0.96
52-week change 3-65.85%
S&P500 52-week change 3-3.56%
52-week high 31,678.00
52-week low 3414.00
50-day moving average 3473.55
200-day moving average 3768.66

Share statistics

Avg vol (3-month) 3152.99k
Avg vol (10-day) 392.42k
Shares outstanding 596.08M
Implied shares outstanding 6N/A
Float 862.68M
% held by insiders 19.06%
% held by institutions 167.11%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 330 May 2018

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Dec 2021

Profitability

Profit margin 13.31%
Operating margin (ttm)14.66%

Management effectiveness

Return on assets (ttm)6.21%
Return on equity (ttm)12.67%

Income statement

Revenue (ttm)142.8M
Revenue per share (ttm)1.71
Quarterly revenue growth (yoy)14.50%
Gross profit (ttm)82.64M
EBITDA 31.46M
Net income avi to common (ttm)19.01M
Diluted EPS (ttm)0.21
Quarterly earnings growth (yoy)117.10%

Balance sheet

Total cash (mrq)109.02M
Total cash per share (mrq)1.26
Total debt (mrq)9.34M
Total debt/equity (mrq)4.99
Current ratio (mrq)4.92
Book value per share (mrq)2.17

Cash flow statement

Operating cash flow (ttm)25.45M
Levered free cash flow (ttm)10.13M